Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Dahiya
Safety and Efficacy of Axicabtagene Ciloleucel (Axi-Cel) in Older Patients: Results From the Us Lymphoma Car-T Consortium
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Optical and Thermal Investigations on Vanadyl Doped Zinc Lithium Borate Glasses
Journal of Asian Ceramic Societies
Composites
Ceramics
Related publications
Preliminary Results of Earlier Steroid Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Product Characteristics Associated With in Vivo Expansion of Anti-Cd19 Car T Cells in Patients Treated With Axicabtagene Ciloleucel (Axi-Cel)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Axicabtagene Ciloleucel (Axi-Cel; KTE-C19) in Patients With Refractory Aggressive Non-Hodgkin Lymphoma (NHL): Long-Term Follow-Up of the Pivotal Zuma-1 Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Outcomes of Patients ≥ 65 Years of Age in Zuma-1, a Pivotal Phase 1/2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Refractory Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Safety and Efficacy of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphomas
Therapeutic Advances in Hematology
Hematology
Axicabtagene Ciloleucel for CD19+ Plasmablastic Lymphoma
American Journal of Hematology
Hematology
Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated With Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Safety and Efficacy of Mogamulizumab in Patients With Adult T-Cell Leukemia-Lymphoma in Japan: Interim Results of Postmarketing All-Case Surveillance
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
